Solar Industries signs ₹12,951 Cr all-cash deal for Omnia, a target with more FY26 revenue than its own

On Monday, September 14, Solar Industries India told the exchanges that Solar SA Investments Proprietary Limited, a wholly owned step-down subsidiary, has signed definitive agreements to acquire 100% of the issued ordinary shares of Omnia Holdings Limited (JSE: OMN), other than treasury shares, for ZAR 134.5 per share in cash — a total consideration of approximately US$1.355 billion, i.e. ₹12,951 crore. Omnia, a Johannesburg-headquartered chemicals group incorporated in 1953, supplies the mining, agriculture and chemicals industries from a physical presence in 23 countries. On completion, the filing states, Omnia will be delisted from the Johannesburg Stock Exchange and the A2X Markets exchange.

For scale: at the September 11 close of ₹22,290 and 9.05 crore shares outstanding, Solar's market capitalisation is roughly ₹2,01,702 crore — the cash consideration works out to about 6.4% of market cap. Both filings reached the exchange during Monday's session (12:22 and 12:30 IST); the price series available to this report ends at the September 11 close, so the market's reaction to the announcement is not yet recorded here. The filings do not state how the consideration will be funded.

Omnia serves customers in more than 40 countries through over 70 distribution centres and employs more than 3,500 people, with international markets including Australia, the United States, Canada, Brazil and Indonesia alongside Southern and Western Africa. The strategic case in the press release rests on two legs. First, BME, the mining segment, brings surface bulk explosives, electronic initiation systems and blasting services that the release says would combine with Solar's explosives and initiating-systems leadership into an integrated global blasting platform. Second, vertical integration: Omnia's ammonium nitrate and nitric acid manufacturing is expected — in the company's words — to strengthen supply security, raw-material availability and long-term cost competitiveness across the explosives value chain. The agriculture segment, built on the proprietary Nutriology® model and Agribio biological solutions, gives Solar what Nuwal called a meaningful entry into crop nutrition.

The revenue comparison is the striking part. Omnia's FY26 revenue of ₹13,307 crore is larger than Solar's own FY26 consolidated revenue of ₹9,838 crore (the four quarters ended March 2026, summed from exchange filings) — and roughly equal to the ₹14,000 crore revenue guidance Solar set for FY27 in its August results release. In other words, if the deal completes, Solar is buying a business of approximately its own current size, for about 6.4% of its market value. That arithmetic reflects the two companies' very different profitability profiles — Solar earned ₹666 crore of consolidated net profit in Q1 FY27 alone at a 27.7% operating margin, while the filings state only that Omnia is net cash positive, disclosing no profit figures — so the earnings contribution of the acquired revenue remains an open question the filings do not answer.

The stock enters the announcement near the top of its range: the September 11 close of ₹22,290 is up 23.5% over the 60 sessions shown, up 8.2% since the September 2 close that preceded the rumour-verification episode, and 1.3% below the 52-week adjusted high of ₹22,595 set on September 9. It is 91% above the 52-week low of ₹11,646 from December 18, 2025. Whether the deal itself was already partly in the price — the clarification session's 4.4% move and record volume suggest the market was trading the possibility — is inference; what the filings establish is that the company said on September 3 there was no disclosable material event, and signed one on September 14.

The acquisition lands on top of an accelerating P&L. Q1 FY27 consolidated revenue of ₹3,668 crore was up 70% on Q1 FY26's ₹2,154 crore, with net profit of ₹666 crore against ₹353 crore — an 89% rise. The August 13 results release reported the defence business up 123% YoY, international explosives up 65%, domestic explosives up 52%, an order book of ₹21,350 crore, and FY27 revenue guidance of ₹14,000 crore. Trailing-twelve-month consolidated net profit, summed from the last four reported quarters, stands at ₹2,051 crore. The same release noted a separately announced proposed investment of ₹12,700 crore in Maharashtra for the defence and aerospace platform — meaning the Omnia consideration is the second five-figure-crore commitment the company has disclosed this year.